← Back to exploreEris Biotech
Healthcare & Life Sciences~2 peopleLehi, UT, USA
Our drugs engage the immune system to fight tumors
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
Funding Timeline
No funding rounds recorded yet.
Signals
- Pressurl: https://news.google.com/rss/articles/CBMid0FVX3lxTE5QNXNmNWdfN2pnbnBhcHJ2RXl3ZGRIVW5rTHd3cmZ2OEZSNS1zOEtQODA3Ukc5U0RXS0dWRWloSmdOazFOWF91OFRwU0JXdGkzX25IZlRPSGkzeHFvM3pnV200b2E1WHFpUnZNZDlzR19BNmxjbjdj?oc=5 · headline: SheTech Interns Interview Evita Weagel · publication: techbuzznews.comgoogle_news · 9/15/2026